CGM-driven personalized exercise medicine: exercise snacks to combat hyperglycemia in patients with type 2 diabetes mellitus or pre-diabetes

Not Applicable

Recruiting

• Conditions: E11; R73.0; Type 2 diabetes mellitus; Abnormal glucose tolerance test

• Registration Number: DRKS00033149
• Lead Sponsor: Deutsche Sporthochschule Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

pre diabetes (HbA1c 5,7 - 6,4), type 2 diabetes mellitus (HbA1c = 6,5%)

Exclusion Criteria

insulin therapy, heart failure (NYHA II-IV, LVEF = 55), coronary heart disease (CHD), heart arrhythmia that requires treatment, peripheral artery disease (PAD) Fontaine stage III and IV, any disease or condition that would limit the performance of exercise snacks (e.g. kidney disease, neurological disease), oncologic illness (< 5 Jahre), psychiatric illness and/or addiction, acute and chronic infections (HIV, hepatitis), change in eating behaviour (<4 weeks), uptake of an exercise program (<4 weeks), = 1x/week sport or exercise training, pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mean 24h glucose, postprandial glucose area under the curve (PPG AUC), rates of hyperglycaemia, time spent in hyperglycemia

Secondary Outcome Measures

Name	Time	Method
Time in Range (TiR), Time above Range (TaR), Time below Range (TbR), rates of hypoglycaemia, qualitative data about the feasibility of performing exercise snacks in everyday life, activity profile and sitting time